Boston University's and National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts; Departments of Medicine, Biostatistics and Epidemiology, Boston University Schools of Medicine and Public Health, Boston, Massachusetts.
Boston University's and National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts; Departments of Medicine, Biostatistics and Epidemiology, Boston University Schools of Medicine and Public Health, Boston, Massachusetts.
JACC Cardiovasc Imaging. 2018 Jan;11(1):1-11. doi: 10.1016/j.jcmg.2017.08.007. Epub 2017 Oct 5.
The purpose of this study was to describe the temporal trends in prevalence of left ventricular systolic dysfunction (LVSD) in individuals without and with heart failure (HF) in the community over a 3-decade period of observation.
Temporal trends in the prevalence and management of major risk factors may affect the epidemiology of HF.
We compared the frequency, correlates, and prognosis of LVSD (left ventricular ejection fraction [LVEF] <50%) among Framingham Study participants without and with clinical HF in 3 decades (1985 to 1994, 1995 to 2004, and 2005 to 2014).
Among participants without HF (12,857 person-observations, mean age 53 years, 56% women), the prevalence of LVSD on echocardiography decreased (3.38% in 1985 to 1994 vs. 2.2% in 2005 to 2014; p < 0.0001), whereas mean LVEF increased (65% vs. 68%; p < 0.001). The elevated risk associated with LVSD (∼2- to 4-fold risk of HF or death) remained unchanged over time. Among participants with new-onset HF (n = 894, mean age 75 years, 52% women), the frequency of heart failure with preserved ejection fraction (HFpEF) increased (preserved LVEF ≥50%: 41.0% in 1985 to 1994 vs. 56.17% in 2005 to 2014; p < 0.001) and heart failure with reduced ejection fraction (HFrEF) decreased (reduced LVEF <40%: 44.10% vs. 31.06%; p = 0.002), whereas heart failure with midrange LVEF remained unchanged (LVEF 40% to <50%: 14.90% vs. 12.77%; p = 0.66). Cardiovascular mortality associated with HFrEF declined across decades (hazard ratio: 0.61; 95% confidence interval: 0.39 to 0.97), but remained unchanged for heart failure with midrange LVEF and HFpEF. Approximately 47% of the observed increase in LVEF among those without HF and 75% of the rising proportion of HFpEF across decades was attributable to trends in risk factors, especially a decline in the prevalence of coronary heart disease among those with HF.
The profile of HF in the community has changed in recent decades, with a lower prevalence of LVSD and an increased frequency of HFpEF, presumably due to concomitant risk factor trends.
本研究旨在描述 30 年来社区中无心力衰竭(HF)和有心力衰竭个体左心室收缩功能障碍(LVSD)的流行趋势。
主要危险因素的流行趋势和管理可能会影响 HF 的流行病学。
我们比较了 Framingham 研究参与者在 3 个 10 年期间(1985 年至 1994 年、1995 年至 2004 年和 2005 年至 2014 年)无临床 HF 和有临床 HF 时 LVSD(左心室射血分数[LVEF]<50%)的频率、相关性和预后。
在无 HF 的参与者中(12857 人年观察,平均年龄 53 岁,56%为女性),超声心动图上 LVSD 的患病率下降(1985 年至 1994 年为 3.38%,2005 年至 2014 年为 2.2%;p<0.0001),而平均 LVEF 增加(65%比 68%;p<0.001)。与 LVSD 相关的风险增加(HF 或死亡的风险约为 2-4 倍)随着时间的推移保持不变。在新发 HF 患者中(n=894,平均年龄 75 岁,52%为女性),射血分数保留型心力衰竭(HFpEF)的频率增加(保留 LVEF≥50%:1985 年至 1994 年为 41.0%,2005 年至 2014 年为 56.17%;p<0.001),射血分数降低型心力衰竭(HFrEF)减少(LVEF<40%:44.10%比 31.06%;p=0.002),而中间范围 LVEF 的心力衰竭保持不变(LVEF 40%至<50%:14.90%比 12.77%;p=0.66)。HFrEF 与心血管死亡率随着时间的推移呈下降趋势(风险比:0.61;95%置信区间:0.39 至 0.97),但中间范围 LVEF 和 HFpEF 的心力衰竭死亡率保持不变。无 HF 患者中 LVEF 升高的约 47%和 HFpEF 升高的 75%归因于危险因素的趋势,尤其是 HF 患者中冠心病的患病率下降。
最近几十年,社区中 HF 的特征发生了变化,LVSD 的患病率降低,HFpEF 的发生率增加,推测这可能是由于同时存在危险因素的趋势。